These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 10891560)
1. Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas. Gray SG; Hartmann W; Eriksson T; Ekstrom C; Holm S; Kytola S; von Schweinitz D; Pietsch T; Larsson C; Kogner P; Sandstedt B; Ekstrom TJ Int J Mol Med; 2000 Aug; 6(2):161-9. PubMed ID: 10891560 [TBL] [Abstract][Full Text] [Related]
2. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma. Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438 [TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma. Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249 [TBL] [Abstract][Full Text] [Related]
4. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Yamada S; Ohira M; Horie H; Ando K; Takayasu H; Suzuki Y; Sugano S; Hirata T; Goto T; Matsunaga T; Hiyama E; Hayashi Y; Ando H; Suita S; Kaneko M; Sasaki F; Hashizume K; Ohnuma N; Nakagawara A Oncogene; 2004 Aug; 23(35):5901-11. PubMed ID: 15221005 [TBL] [Abstract][Full Text] [Related]
5. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992 [TBL] [Abstract][Full Text] [Related]
6. Molecular control of the cell cycle in cancer: biological and clinical aspects. Møller MB Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137 [TBL] [Abstract][Full Text] [Related]
7. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia. Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma. Pietsch T; Fonatsch C; Albrecht S; Maschek H; Wolf HK; von Schweinitz D Lab Invest; 1996 Apr; 74(4):809-18. PubMed ID: 8606490 [TBL] [Abstract][Full Text] [Related]
10. beta-Catenin and met deregulation in childhood Hepatoblastomas. Ranganathan S; Tan X; Monga SP Pediatr Dev Pathol; 2005; 8(4):435-47. PubMed ID: 16211454 [TBL] [Abstract][Full Text] [Related]
11. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity. Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019 [TBL] [Abstract][Full Text] [Related]
12. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications. Sabah M; Cummins R; Leader M; Kay E Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203 [TBL] [Abstract][Full Text] [Related]
13. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors. Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983 [TBL] [Abstract][Full Text] [Related]
15. Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine. Yao R; Lemon WJ; Wang Y; Grubbs CJ; Lubet RA; You M Neoplasia; 2004; 6(5):569-77. PubMed ID: 15548366 [TBL] [Abstract][Full Text] [Related]
16. Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma. Eriksson T; Frisk T; Gray SG; von Schweinitz D; Pietsch T; Larsson C; Sandstedt B; Ekström TJ Exp Cell Res; 2001 Oct; 270(1):88-95. PubMed ID: 11597130 [TBL] [Abstract][Full Text] [Related]
18. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas. Koch A; Weber N; Waha A; Hartmann W; Denkhaus D; Behrens J; Birchmeier W; von Schweinitz D; Pietsch T J Pathol; 2004 Dec; 204(5):546-54. PubMed ID: 15538750 [TBL] [Abstract][Full Text] [Related]
19. Cell cycle regulators in bladder cancer: relationship to schistosomiasis. Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562 [TBL] [Abstract][Full Text] [Related]
20. Gene profiling of cell cycle progression through S-phase reveals sequential expression of genes required for DNA replication and nucleosome assembly. van der Meijden CM; Lapointe DS; Luong MX; Peric-Hupkes D; Cho B; Stein JL; van Wijnen AJ; Stein GS Cancer Res; 2002 Jun; 62(11):3233-43. PubMed ID: 12036939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]